No Data
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3
Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth
Assertio Therapeutics: A Strong Buy on Robust Financial Performance and Strategic Growth Potential
Assertio Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Earnings Call: Assertio Holdings Reports Q2 2024 With Rolvedon Growth
No Data
No Data
White_Shadow OP : love this stock, way undervalued